NVO - Novo Nordisk's Wegovy improves kidney health in addition to weight loss: study
2024-05-25 08:41:46 ET
More on Novo Nordisk
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
- Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
- Novo Nordisk once weekly insulin fails to get thumbs up from majority of FDA advisors
- Novo weight loss therapy cuts mortality risk in kidney disease